Colgate-Palmolive’s closely balanced 54.5% market-implied probability of missing Q3 2026 earnings centers on the October 30 release, where consensus targets adjusted EPS near $0.93–0.95 and revenue around $5.34–5.60 billion. The company has beaten or met EPS estimates in recent quarters, including an in-line $0.99 result in Q2, yet posted a revenue miss versus consensus amid 2.4% organic sales growth and margin expansion. Traders weigh steady demand for core oral-care and personal-care products against potential FX headwinds, pet-food softness, and any shift in full-year guidance. With the report just days away and limited fresh data since Q2, the odds reflect uncertainty over whether volume trends and cost controls will clear the bar.